Citrine Capital’s IBM IBM Stock Holding History

Citrine Capital’s Portfolio IBM Stock Details IBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$386K	Buy	1,372 +14	+1%	+$3.53K	0.14%	39
2026 Q1	$329K	Buy	+1,358	New	+$367K	0.14%	39

Other funds holding IBM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citrine Capital's IBM Position: Q2 2026 in Review

Citrine Capital increased its IBM (IBM) stake by 1% in Q2 2026, buying an estimated $3.53K and bringing the position to 1,372 shares worth $386K. The position accounts for 0.14% of the portfolio, ranked #39.

Citrine Capital first reported a position in IBM in Q1 2026 and has held it in 2 quarters since. 3,611 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

Citrine Capital held 1,372 shares of IBM worth $386K as of Q2 2026.
Citrine Capital bought 14 IBM shares in Q2 2026, an estimated $3.53K.
IBM made up 0.14% of Citrine Capital's portfolio in Q2 2026, its #39 holding.
Citrine Capital first reported a position in IBM in Q1 2026 and has held it in 2 quarters since.
3,611 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Citrine Capital's 13F filing for Q2 2026, filed 23 Jul 2026.